Joshua Fitch is an editor for Contemporary Pediatrics.
Measles Outbreak Continues to Grow, Affects Multiple States
Clinician warns that as immunization rates decrease, outbreaks of vaccine preventable diseases will continue.
Household Transmission of Influenza Increased in 2021-2022 Vs Past Seasons
Though more research is needed to determine reasons for the association, a study published in JAMA Network revealed the 2021-2022 influenza season was associated with a significantly higher household transmission risk compared to pre-pandemic seasons.
The Clinical Takeaways of the RSV Immunizations
The panel discusses the importance of discussing the immunizations with patients now, as well as the value of them in future seasons.
Differing Strategies for Monitoring Influenza and COVID-19 in Schools
In 43 of 154 school weeks, air samples were positive for influenza A virus (IAV) while SARS-CoV-2 was positive in air samples in 101 of 154 school weeks.
Voluntary Recall for Infant Formula Due to Possible Bacterial Contamination
Over 675,000 cans of specialty infant formula for cow’s milk allergy have been voluntarily recalled by Reckitt/Mead Johnson Nutrition because of a possible contamination with Cronobacter sakazakii.
RSV Roundtable: Nirsevimab's Impact
In the third installment of RSV Roundtable, our panel discusses the impact nirsevimab has had this RSV season.
RSV Roundtable: Disease Education, Vaccine Hesitancy, and Awareness
In the second installment of the RSV Roundtable, our panel explains how they are educating patients and parents when it comes to RSV, vaccines and preventive measures, and limited treatment availability.
CDC: 2022-2023 Influenza Season 'High Severity'
Last year was the fourth season to be classified as high severity since the 2009 influenza A(H1N1) pandemic.
Quadrivalent Influenza Vaccines Provide Higher Immunogenicity Against B Lineage vs Trivalent
Overall, the study authors concluded that the immunogenicity of QIV and TIV was similar for common influenza ingredients for children aged 6 to 35 months.
FDA: COVID-19 Moderna Vaccine Dose Needs to be Adjusted for Pediatric Population
The federal agency was made aware some health care providers had administered the full single dose vial of the vaccine, which contains “notably more” volume than the 0.25 mL volume indicated for children aged 6 months to 11 years.
Discussing the Upcoming RSV Season, New Tools, and Vaccine Hesitancy
Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses the benefits of having new tools to fight RSV in infants, potential vaccine hesitancy, and RSV trends currently being observed.
CDC Issues Health Advisory Alert After Increases in RSV Activity
Due to increased RSV activity in the southeast United States, the CDC has issued an official Health Alert Network Health Advisory. The federal agency recommends clinicians prepare to implement recently FDA-approved prevention methods.
Original mRNA Vaccines Protect Children From COVID-19-associated ED visits
The CDC reports the original COVID-19 monovalent and bivalent vaccines helped reduce emergency department or urgent care encounters for children aged 6 months to 5 years.
Indication for Ebola Vaccine Expanded to Pediatric Patients
The vaccine has been approved since late 2019 for adults age 18 and older.
Voluntary Recall of Atovaquone Oral Suspension Due to Potential Bacillus cereus Contamination
The pneumonia drug Atovaquone oral suspension, USP 750mg/5mL, has been voluntarily recalled due to potential Bacillus cereus contamination.
2 Commerce Drive Cranbury, NJ 08512